PMC:7358770 / 30930-31082 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T296","span":{"begin":18,"end":32},"obj":"Body_part"},{"id":"T297","span":{"begin":93,"end":98},"obj":"Body_part"},{"id":"T298","span":{"begin":112,"end":120},"obj":"Body_part"},{"id":"T299","span":{"begin":139,"end":143},"obj":"Body_part"}],"attributes":[{"id":"A296","pred":"fma_id","subj":"T296","obj":"http://purl.org/sig/ont/fma/fma82746"},{"id":"A297","pred":"fma_id","subj":"T297","obj":"http://purl.org/sig/ont/fma/fma63083"},{"id":"A298","pred":"fma_id","subj":"T298","obj":"http://purl.org/sig/ont/fma/fma62871"},{"id":"A299","pred":"fma_id","subj":"T299","obj":"http://purl.org/sig/ont/fma/fma7195"}],"text":"elta inulin-based polysaccharide adjuvant on day 3 post-challenge can significantly increase serum neutralizing-antibody titers and reduce lung virus ti"}

    LitCovid-PD-UBERON

    {"project":"LitCovid-PD-UBERON","denotations":[{"id":"T18","span":{"begin":93,"end":98},"obj":"Body_part"},{"id":"T19","span":{"begin":139,"end":143},"obj":"Body_part"}],"attributes":[{"id":"A18","pred":"uberon_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"},{"id":"A19","pred":"uberon_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"}],"text":"elta inulin-based polysaccharide adjuvant on day 3 post-challenge can significantly increase serum neutralizing-antibody titers and reduce lung virus ti"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T343","span":{"begin":139,"end":143},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T344","span":{"begin":139,"end":143},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"},{"id":"T345","span":{"begin":144,"end":149},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"}],"text":"elta inulin-based polysaccharide adjuvant on day 3 post-challenge can significantly increase serum neutralizing-antibody titers and reduce lung virus ti"}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T458","span":{"begin":5,"end":11},"obj":"Chemical"},{"id":"T459","span":{"begin":18,"end":32},"obj":"Chemical"},{"id":"T460","span":{"begin":33,"end":41},"obj":"Chemical"}],"attributes":[{"id":"A458","pred":"chebi_id","subj":"T458","obj":"http://purl.obolibrary.org/obo/CHEBI_15443"},{"id":"A459","pred":"chebi_id","subj":"T459","obj":"http://purl.obolibrary.org/obo/CHEBI_18154"},{"id":"A460","pred":"chebi_id","subj":"T460","obj":"http://purl.obolibrary.org/obo/CHEBI_60809"}],"text":"elta inulin-based polysaccharide adjuvant on day 3 post-challenge can significantly increase serum neutralizing-antibody titers and reduce lung virus ti"}

    LitCovid-PMC-OGER-BB

    {"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T889","span":{"begin":18,"end":32},"obj":"CHEBI:18154;CHEBI:18154"},{"id":"T890","span":{"begin":33,"end":41},"obj":"CHEBI:60809;CHEBI:60809"},{"id":"T891","span":{"begin":93,"end":98},"obj":"UBERON:0001977"},{"id":"T892","span":{"begin":112,"end":120},"obj":"GO:0042571"},{"id":"T893","span":{"begin":139,"end":143},"obj":"UBERON:0002048"},{"id":"T894","span":{"begin":144,"end":149},"obj":"NCBITaxon:10239"},{"id":"T53532","span":{"begin":8,"end":19},"obj":"NCBITaxon:11118"},{"id":"T91671","span":{"begin":56,"end":70},"obj":"CHEBI:18154;CHEBI:18154"},{"id":"T57497","span":{"begin":71,"end":80},"obj":"CHEBI:60809;CHEBI:60809"},{"id":"T72616","span":{"begin":126,"end":137},"obj":"NCBITaxon:11118"}],"text":"elta inulin-based polysaccharide adjuvant on day 3 post-challenge can significantly increase serum neutralizing-antibody titers and reduce lung virus ti"}